Details

Oblikovanje sistema kakovosti validacije računalniških sistemov v farmacevtski industriji : magistrsko delo
ID Sallubier, Tomaž (Author), ID Rusjan, Borut (Mentor) More about this mentor... This link opens in a new window

URLURL - Presentation file, Visit http://www.cek.ef.uni-lj.si/magister/sallubier1431-B.pdf This link opens in a new window

Language:Slovenian
Keywords:farmacevtska industrija, informatika, informacijski sistemi, kvaliteta, regulacija, življenjski ciklus, primeri
Work type:Master's thesis/paper
Typology:2.09 - Master's Thesis
Organization:EF - School of Economics and Business
Place of publishing:Ljubljana
Publisher:[T. Sallubier]
Year:2014
Number of pages:II, 62 str.
PID:20.500.12556/RUL-70567 This link opens in a new window
UDC:005.336.3
COBISS.SI-ID:22290406 This link opens in a new window
Publication date in RUL:10.07.2015
Views:2278
Downloads:217
Metadata:XML DC-XML DC-RDF
:
SALLUBIER, Tomaž, 2014, Oblikovanje sistema kakovosti validacije računalniških sistemov v farmacevtski industriji : magistrsko delo [online]. Master’s thesis. Ljubljana : T. Sallubier. [Accessed 30 April 2025]. Retrieved from: http://www.cek.ef.uni-lj.si/magister/sallubier1431-B.pdf
Copy citation
Share:Bookmark and Share

Secondary language

Language:Unknown
Title:Design of the quality management system for computer system validation in the pharmaceutical industry
Keywords:pharmaceutical industry, informatics, information systems, quality, regulation, life cycle, cases

Similar documents

Similar works from RUL:
  1. Study of SPOT 14 protein gene expression in non-small cell lung cancer tissue
  2. Study of folate receptro ß gene expression in non-small cell lung cancer tissue
  3. Study of fatty acid synthase gene expression in non-small cell lung cancer tissue
  4. Preučevanje ekspresije gena za LDL receptor v nedrobnoceličnem pljučnem rakavem tkivu
  5. Analysis of clinical applicability of SR-A1 receptor expression in non small cell lung cancer tissue
Similar works from other Slovenian collections:
  1. PD-L1 expression can be regarded as prognostic factor for survival of non-small cell lung cancer patients after chemoradiotherapy
  2. Novosti v zdravljenju pljučnega raka ASCO, Chicago, 1.-5. junij 2012
  3. Pogovor o zdravilu brigatinib
  4. Detection of EGFR variants in plasma
  5. Zbornik

Back